CLINICAL_TRIALS
research
· 2025-10-10
Clinical Trial Update: Sequential Treatment of Cabozantinib for Advanced Renal Cell Carcinoma (RCC) [Phase 2]
Summary
A Phase 2 clinical trial is evaluating sequential cabozantinib therapy for advanced renal cell carcinoma; the study is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Texas Southwestern Medical Center | Conditions: RCC, Renal Cell Carcinoma | Phase 2 | Status: RECRUITING